Lipid-lowering drugs as primary prevention in general practice: Do patients reach guideline goals and continue treatment? ADDITION Denmark

References

• Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, . Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267–78.
   PubMed Web of Science ®Google Scholar
• Dansk selskab for almen medicin. Forebyggelse af hjertesygdom i almen praksis - med særligt henblik pådyslipidæmi [Prevention of heart disease in general practice – with particular emphasis on dyslipidemia]. Dansk selskab for almen medicin; 1998.
   Google Scholar
• Thomsen T, Christensen B, Hildebrandt P, Iversen HK, Larsen ML, Sillesen H, . Kliniske retningslinier for forebyggelse af kardiovaskulær sygdom i Danmark [Clinical guidelines for prevention of cardiovascular disease in Denmark]. Tillæg til Cardiologisk Forum; August 2004.
   Google Scholar
• Erhardt LR, Hobbs FD. A global survey of physicians’ perceptions on cholesterol management: The From The Heart study. Int J Clin Pract 2007;61:1078–85.
   PubMed Web of Science ®Google Scholar
• Levine AP, Mikhailidis DP, Moross T, Benson K, Gor M. Achieving vascular risk factor targets: A survey of a London general practice. Angiology 2008;59:36–46.
   PubMed Web of Science ®Google Scholar
• Schultz JS, O'Donnell JC, McDonough KL, Sasane R, Meyer J. Determinants of compliance with statin therapy and low-density lipoprotein cholesterol goal attainment in a managed care population. Am J Manag Care 2005;11: 306–12.
   PubMed Web of Science ®Google Scholar
• Pearson TA, Laurora I, Chu H, Kafonek S. The lipid treatment assessment project (L-TAP): A multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459–67.
   PubMed Web of Science ®Google Scholar
• Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: Three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331–42.
   PubMed Web of Science ®Google Scholar
• Vinker S, Shani M, Baevsky T, Elhayany A. Adherence with statins over 8 years in a usual care setting. Am J Manag Care 2008;14:388–92.
   PubMed Web of Science ®Google Scholar
• Mann DM, Allegrante JP, Natarajan S, Halm EA, Charlson M. Predictors of adherence to statins for primary prevention. Cardiovasc Drugs Ther 2007;21:311–16.
   PubMed Web of Science ®Google Scholar
• McGinnis B, Olson KL, Magid D, Bayliss E, Korner EJ, Brand DW, . Factors related to adherence to statin therapy. Ann Pharmacother 2007;41:1805–11.
   PubMed Web of Science ®Google Scholar
• Caspard H, Chan AK, Walker AM. Determinants of the differences in LDL-cholesterol after initiation of statin treatment. Ann Pharmacother 2006;40:21–6.
   PubMed Web of Science ®Google Scholar
• Bouchard MH, Dragomir A, Blais L, Berard A, Pilon D, Perreault S. Impact of adherence to statins on coronary artery disease in primary prevention. Br J Clin Pharmacol 2007;63:698–708.
   PubMed Web of Science ®Google Scholar
• Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, . Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. Eur J Clin Pharmacol 2005;61:667–74.
   PubMed Web of Science ®Google Scholar
• Caspard H, Chan AK, Walker AM. Compliance with a statin treatment in a usual-care setting: Retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia. Clin Ther 2005;27:1639–46.
   PubMed Web of Science ®Google Scholar
• Natarajan N, Putnam RW, Yip AM, Frail D. Family practice patients’ adherence to statin medications. Can Fam Physician 2007;53:2144–5.
   PubMedGoogle Scholar
• Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, . Persistence of use of lipid-lowering medications: A cross-national study. JAMA 1998;279:1458–62.
   PubMed Web of Science ®Google Scholar
• Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: What doctors believe and patients actually do. Br J Clin Pharmacol 2001;51:615–22.
   PubMed Web of Science ®Google Scholar
• Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G, . The ADDITION study: Proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000;24(Suppl 3):S6–11.
   Google Scholar
• Christensen JO, Sandbaek A, Lauritzen T, Borch-Johnsen K. Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms. Diabetologia 2004;47:1566–73.
   PubMed Web of Science ®Google Scholar
• Graversen L, Christensen B, Borch-Johnsen K, Lauritzen T, Sandbaek A. General practitioners’ adherence to guidelines on management of dyslipidaemia: ADDITION-Denmark. Scand J Prim Health Care 2010;28:47–54.
   PubMed Web of Science ®Google Scholar
• Bjerrum L. Pharmacoepidemiological studies of polypharmacy: Methodological issues, population estimates, and influence of practice patterns: PhD thesis, Odense University; 1998.
   Google Scholar
• Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–8.
   PubMed Web of Science ®Google Scholar
• Frank L. Epidemiology. When an entire country is a cohort. Science 2000;287:2398–9.
   PubMed Web of Science ®Google Scholar
• Perreault S, Ellia L, Dragomir A, Cote R, Blais L, Berard A, . Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med 2009;122:647–55.
   PubMed Web of Science ®Google Scholar
• Perreault S, Dragomir A, Blais L, Berard A, Lalonde L, White M, . Impact of better adherence to statin agents in the primary prevention of coronary artery disease. Eur J Clin Pharmacol 2009;65:1013–24.
   PubMed Web of Science ®Google Scholar
• Midlov P, Ekesbo R, Johansson L, Gerward S, Persson K, Nerbrand C, . Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey. Scand J Prim Health Care 2008;26:154–9.
   PubMed Web of Science ®Google Scholar